These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3944070)

  • 41. Continuation treatment with adjunctive imipramine in schizophrenia.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA; Aseniero MA
    Psychopharmacol Bull; 1992; 28(3):303-7. PubMed ID: 1480734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Depressive states during the clinical treatment of 280 schizophrenic inpatients (author's transl)].
    Möller HJ; von Zerssen DV
    Pharmacopsychiatria; 1981 Sep; 14(5):172-9. PubMed ID: 7291301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Action and tolerance of dothiepin hydrochloride (Prothiaden) in depressive states during the evolution of psychotic disorders].
    Sechter D; De Sahb R; Boudet A; Leutenegger E
    Encephale; 1994; 20(4):445-50. PubMed ID: 7988409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Psychopathology of endogenous anesthetic depression].
    Baranov PA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):66-71. PubMed ID: 2167590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA; Aderounmu AF
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 48. Postpsychotic depression.
    Prakash R
    Arch Gen Psychiatry; 1983 Sep; 40(9):1036. PubMed ID: 6615153
    [No Abstract]   [Full Text] [Related]  

  • 49. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
    Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Depression in protracted simple schizophrenia (on the problem of correlation between positive and negative disorders)].
    Drobizhev MIu; Luk'ianova LL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):60-4. PubMed ID: 1650100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression.
    Siris SG; Strahan A; Mandeli J; Cooper TB; Casey E
    Schizophr Res; 1988; 1(1):31-5. PubMed ID: 3154504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
    Mandel MR; Severe JB; Schooler NR; Gelenberg AJ; Mieske M
    Arch Gen Psychiatry; 1982 Feb; 39(2):197-203. PubMed ID: 6121543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinico-diagnostic criteria of protracted anxiety-related depression in manic-depressive psychosis and attacks of schizophrenia].
    Dmitriev AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):73-6. PubMed ID: 2750387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Course and prognosis of the syndrome of doubles.
    Christodoulou GN
    J Nerv Ment Dis; 1978 Jan; 166(1):68-72. PubMed ID: 619004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Depressive syndromes within the scope of schizophrenic psychoses].
    Hinterhuber H; Neumann R
    Wien Med Wochenschr; 1985 Sep; 135(18):435-41. PubMed ID: 3933187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The clinical course of schizophrenia associated with anesthetic depression].
    Baranov PA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):75-80. PubMed ID: 2158732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histories of substance abuse, panic and suicidal ideation in schizophrenic patients with histories of post-psychotic depressions.
    Siris SG; Mason SE; Shuwall MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):609-17. PubMed ID: 8362074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Depression in schizophrenia].
    Ivanets NN; Kinkul'kina MA
    Vestn Ross Akad Med Nauk; 2008; (10):55-63. PubMed ID: 19140400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depression in schizophrenia: clinical and pharmacological variables.
    Mauri MC; Bravin S; Mantero M; Invernizzi G
    Schizophr Res; 1995 Feb; 14(3):261-2. PubMed ID: 7766539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.